Medication reference
Flumazenil
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- flumazenil
Source ID
H51-A59D80C3A1B063A2EC9EEECA - Generic name
- Flumazenil
Source ID
H51-DDECFC27E31115782F6CFF70 - Class
- Toxicology and reversal
Source ID
H51-D6A1CD294D0EC4B229578E7C - Subclass
- Benzodiazepine antagonist
Source ID
H51-9E895B31D68D97806ABD0083 - Primary uses
- Reversal of benzodiazepine sedation in selected patients
Source ID
H51-4BF0F6586649C415229B8253
- Reversal of benzodiazepine sedation in selected patients
- Mechanism
- Competitively blocks the benzodiazepine site on GABA-A receptors.
Source ID
H51-AB34B9B59FE23AF31F4E2BF2 - Mechanism level
- drug_specific
Source ID
H51-E4C937F68D91D789C1710116 - Basic dosing orientation
- Adult / Pediatric selected use | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settings | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settings | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-AE4A7467B35980DEE1FD01A4 - Administration orientation
- Initial 0.2 mg over 15 seconds; additional doses at label intervals; 0.1 mg/mL; Initial 0.2 mg over 15 seconds; additional doses at label intervals
Source ID
H51-3E73CC4582F4B1A01D078C84 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-B93439B713B0C7B05767FE65 - Key safety orientation
- Seizures, acute withdrawal, resedation, and arrhythmia.
Source ID
H51-4991D317F8B2330B73F660F7
- Seizures, acute withdrawal, resedation, and arrhythmia.
- Coverage path
- structured_local_snapshot
Source ID
H51-9C14DCA6BA8B3616ED297AE4 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-34A748B4648A9AF9F843E885 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-D740C5A8C1398B729311B876 - Search text
- Flumazenil Toxicology and reversal Benzodiazepine antagonist Reversal of benzodiazepine sedation in selected patients Competitively blocks the benzodiazepine site on GABA-A receptors. Adult / Pediatric selected use | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settings | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settings | Patient- and indication-specific | See current package insert | IV push Initial 0.2 mg over 15 seconds; additional doses at label intervals; 0.1 mg/mL; Initial 0.2 mg over 15 seconds; additional doses at label intervals Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Seizures, acute withdrawal, resedation, and arrhythmia. Structured GlobalRPh route snapshot
Source ID
H51-18CC0151E816377FA36F9E95 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Flumazenil (opens in a new tab)
Source ID
H51-45904281CCBC9BC48048F2CA - Official access mode
- search
Source ID
H51-5D08C0094553F4D78D2C61BF - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Flumazenil (opens in a new tab)
Source ID
H51-4C4641A1FD7C72E924FD3123 - Official search query
- Flumazenil
Source ID
H51-C942810809610F36A7510A56 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-6E722E705C10051089BFF78F
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for preparation, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status | Notes |
|---|---|---|---|---|---|
Source IDH51-06AB2CDBD38FDDF260E4748FSource IDH51-BD3F5CCEC8D6392C811CDD33 | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settingsSource IDH51-B62D2138B852F6C66DA04336 | 0.1 mg/mLSource IDH51-873AC67B3CE596D1EC0E61E2 | Initial 0.2 mg over 15 seconds; additional doses at label intervalsSource IDH51-ABBC086E4BD63E41807A6CC2 | Use only when ordered and supported by current labeling or institutional policySource IDH51-55A2057EFA3AA3A7F1FC1882 | Avoid routine use in chronic benzodiazepine exposure, mixed proconvulsant overdose, or seizure disorders unless benefit clearly outweighs risk.Source IDH51-1515C3E886D6E75411DD271D |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-E44A24055E48E5F646915402Source IDH51-22BBCB3654AC8A8B57B33417 | Adult / Pediatric selected useSource IDH51-7FB471E445E21D3B4FD344E9 | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settingsSource IDH51-4CC46D9A169F1A2EA5CD8750 | Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settingsSource IDH51-9A1B6B314452D878A8E4F320 | Patient- and indication-specificSource IDH51-BACD3BFD6344E02D8C9C8B09 | See current package insertSource IDH51-B321E2C18E9894FA78CBE592 | Initial 0.2 mg over 15 seconds; additional doses at label intervalsSource IDH51-FF1EB77A6CA91F3E75516650 | Existing GlobalRPh IV push snapshotSource IDH51-C0DE95C51320DAB3177E9D06 | Use only when ordered and supported by current labeling or institutional policy Avoid routine use in chronic benzodiazepine exposure, mixed proconvulsant overdose, or seizure disorders unless benefit clearly outweighs risk.Source IDH51-F1BD0A10A0CF790E9ACC068F |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-CB91C2DB32BEAB2B4483B148 - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-18F6FB4EE1FB74B7A20D3DFB - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-9ECC91D1282D90789F3C1F29
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Reversal of benzodiazepine sedation in selected patients
Source ID
H51-016A8DB5415B1F82FC38DA36
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Seizures, acute withdrawal, resedation, and arrhythmia.
Source ID
H51-EC851316D0F9CE146640B2FE
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Continuous respiratory and neurologic monitoring
Source ID
H51-C2A83520987D2FA9C00DDB1E - Resedation
Source ID
H51-5B29D1B429243985A3A3E2B9
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
flumazenilSource ID
H51-B0CC3DD2B60CFD8E41C68934Generic name
FlumazenilSource ID
H51-1C163C3015365E6BE4C26BC4Brand names
- Romazicon
Source ID
H51-DC143F2B801B67DC0151B681
Class
Toxicology and reversalSource ID
H51-D411902106074537674AD03CSubclass
Benzodiazepine antagonistSource ID
H51-60EBFD0BB660657B3E06F8CASummary
Benzodiazepine antagonist administered in small titrated boluses; can precipitate seizures and withdrawal.Source ID
H51-3FB7CD49DF27B6566E568604Populations
- Adult
Source ID
H51-4BF36B8545661C1C150EA7F8 - Pediatric selected use
Source ID
H51-DD35A8A44B1DDFE22C6844C5
Evidence tier
IV push safety normalization - verify stocked productSource ID
H51-4971129418C3D541D6005582High alert
trueSource ID
H51-97495A9669B011929A344B7FHazardous
falseSource ID
H51-5993F1C581E0F9A2ADDB9EC3Status
ActiveSource ID
H51-A42614378976E3E55312DD53Reviewed
2026-08-29Source ID
H51-F2DBC72D459AB6BB2F8B030FVersion added
1.2Source ID
H51-2E68DB2D3CA597C914A1492ESources
| Label | Url | Kind |
|---|---|---|
Source IDH51-B20F735E87ACF331C3C8B71FSource IDH51-04DF916D7AC4CF656B550BEB | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Flumazenil (opens in a new tab)Source IDH51-1BDA6854570C3BE7EB86ED46 | PrimarySource IDH51-6189FAB664EAD22BE78E2D6C |
Source IDH51-5E50C93BD3AD4B5DECC10CD3Source IDH51-03ACFFB2B81FD0D7D80B7091 | legacy:autoSource IDH51-C67E839090C0FA4615A02EA5 | LegacySource IDH51-A150084A672149CDCC4B1222 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-8D1FC1E39D80F63EB82F431E - Audited on
- 2026-08-30
Source ID
H51-19F0C40C0FA7BD6A7D46D8FC - Level
- amber
Source ID
H51-B57389CC94D9F813A138A12F - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-65B7D1ED2D0357E08D939D1F - Exact current label candidate
- false
Source ID
H51-9C7D755F55333C5606721021 - Numeric support ratio
- 0
Source ID
H51-29480DEC6B49B8DE9614F025 - Reference url count
- 1
Source ID
H51-F2FA073E21A31903D32342DD - Broken reference count
- 0
Source ID
H51-779801E33B323D303C0831DE - Point of use confirmation required
- true
Source ID
H51-CE1F5EE6A5C0AAC8934894DB - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-636B0065BA47115D3FBF06DB - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Flumazenil (opens in a new tab)
Source ID
H51-E82CA68B7A7DB525D4E8E385
Dosing source fields
Id
flumazenilSource ID
H51-A5A8B5F596BD814A6677AF4EGeneric name
FlumazenilSource ID
H51-59C1B5B1CC66C9E8F862F265Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-5A1A7B17FF9B2C7A7182472DPackage insert
- Query name
- Flumazenil
Source ID
H51-F18AB8CC812FB273B1B9A610 - Product and route must match
- true
Source ID
H51-7D70F1DB3049A938D1678F90 - Live current label enabled
- false
Source ID
H51-52BEC780B69E756D8DBD7247 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-97F0F1B0AEC5680BAC411176 - Direct official label access enabled
- true
Source ID
H51-FA08C8E867A021262619C0D5 - Outbound server request required
- false
Source ID
H51-3C1D93FE7C328AE4DDCAACD2 - Local summary status
- not_bundled
Source ID
H51-E579242C96C3A594A4484CDA
Clinical review
- Locally normalized
- false
Source ID
H51-9463D2FC1DBFD36254C4FFED - Reviewed
- 2026-08-29
Source ID
H51-DBCD43F2EF07BD135306E363 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-E7BC296FA4B017DF765A2B53
Clinical release verification
- Audit version
- 3.4
Source ID
H51-487C4E39774F3E5917685037 - Audited on
- 2026-08-30
Source ID
H51-5DB12BBCF4C885022C37EFEB - Level
- amber
Source ID
H51-A7528717B895FE36D26E64A5 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-8D3E68F86D9865427282C8EF - Exact current label candidate
- false
Source ID
H51-FF98B2B2A4C46FB38802481A - Numeric support ratio
- 0
Source ID
H51-0273983B8EC80D1CEA0535CC - Reference url count
- 1
Source ID
H51-DADEF4F17A6456EB0C806033 - Broken reference count
- 0
Source ID
H51-1D2D0C2F06AC527314642A9D - Point of use confirmation required
- true
Source ID
H51-256C6F94A77CE0FCE94F9971 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-665CC2F64ECCC4515E896C46 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Flumazenil (opens in a new tab)
Source ID
H51-763524DE79CAB7219C6BEA10
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- flumazenil
Source ID
H51-F0468BDDD09549323F517F5F - Name
- Flumazenil
Source ID
H51-6F62DAD0E538CCB804264A54 - Brands
- Romazicon
Source ID
H51-4258E0AA1B2E84077A7AE537 - Therapeutic class
- Toxicology and reversal
Source ID
H51-FFAACD71C3BBD09972F9CCE1 - Review version
- 3.1
Source ID
H51-FF5F6008EAD21846B4F3C2F7 - Review date
- 2026-08-30
Source ID
H51-ABB512320CE259F9506F0AA3 - Release status
- no_released_dilution_current_label_review_required
Source ID
H51-5EF4E9AFEE442A2FDEA80A04 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-C82DABAAB52831B6F67A7057 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-3353BA8D1A3A387C7F840831
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-9B1C653030FA4F6724E7247B - Reconstitution concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A0C12D3858124A69E2F8486B - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-688057A34A0CB675826B929E - Appropriate standardized containers
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-8690E1BDAA41D76598E1FE07 - Adult dosing range
- Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settings Initial adult 0.2 mg with titration per label; pediatric dose weight based in selected settings
Source ID
H51-A2808C26F84F0CFE8568DBA1 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-E67745C374B9AD44A5BD86F4 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-F4E539B93F3EEAA1F9DF2B09 - Infusion time
- Initial 0.2 mg over 15 seconds; additional doses at label intervals
Source ID
H51-BB1C5A567E68E0264CF32BF9 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-8435466DCD5F7DB23AEA163C - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-D7928D6AB939D2E784B983B4 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Flumazenil (opens in a new tab)
Source ID
H51-A60DE9A4AF728D0ABD8E1840
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-49415E3B1F53C9BFE3C0C0AA
- Reconstitution concentration
- Primary
- not_found
Source ID
H51-419FAC9FD09ADC4239127F5B
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-70E07A17C57CD81E1C148A06
- Appropriate standardized containers
- Primary
- not_found
Source ID
H51-C3DE0139040881F717A48B2E
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-43CF71406BD473E8440B4992
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-D884E8C33811494053E8F079
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-4ED29EA006C12B2BB69DB61A
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-7E5EFE725127E9E24EA5E5C9
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-A7375FB1B2BAAA53BD597E6D
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-2E43D2639416275ED2E575DB
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-EC156498834F7D8FFB5899B6 - Guide generation allowed
- true
Source ID
H51-83E33D6D821FC7AE4C981917
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-0A20A77C978303363ABA8430 - Guide generation allowed
- false
Source ID
H51-41EBB2F1AE5BFF897BA612E2
- Neonatal
- Applicability
- not_established
Source ID
H51-8641A0FA964068ED896A1835 - Guide generation allowed
- false
Source ID
H51-48238186974C9C7B082CDCC8
- Route presence
- Structured dilution
- false
Source ID
H51-49A331A1DF350A63BB237D3A - Iv push
- true
Source ID
H51-624E5932FAFAE01B83E8359B - Continuous infusion
- true
Source ID
H51-A9718D6869DB9977EC9AC7DD - Pediatric source
- true
Source ID
H51-BEA49774EBCEFFAB53280FC1 - Neonatal source
- false
Source ID
H51-672EA922E2E0A7D73ACD8A04
- Legacy reference
- Status
- not_available
Source ID
H51-768095914F38CD91EC1E803F
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-B37B5AAF03F14BEBFD9B9F34
- Source files
- catalog.json
Source ID
H51-291DA3888478161960BEDD6A - dosing.json
Source ID
H51-56E9C1C4CC3BDCB9AA95E771 - new-in-v1.2.json
Source ID
H51-AA3A9439969C7FD5DE97AC40
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-E9715951279E61CA6020C32B
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-B0CC3DD2B60CFD8E41C68934 | catalog.json/records/108/id | Historical; current review incomplete |
H51-1C163C3015365E6BE4C26BC4 | catalog.json/records/108/generic_name | Historical; current review incomplete |
H51-DC143F2B801B67DC0151B681 | catalog.json/records/108/brand_names/0 | Historical; current review incomplete |
H51-D411902106074537674AD03C | catalog.json/records/108/class | Historical; current review incomplete |
H51-60EBFD0BB660657B3E06F8CA | catalog.json/records/108/subclass | Historical; current review incomplete |
H51-3FB7CD49DF27B6566E568604 | catalog.json/records/108/summary | Historical; current review incomplete |
H51-016A8DB5415B1F82FC38DA36 | catalog.json/records/108/common_uses/0 | Historical; current review incomplete |
H51-06AB2CDBD38FDDF260E4748F | catalog.json/records/108/iv_push/0 | Historical; current review incomplete |
H51-BD3F5CCEC8D6392C811CDD33 | catalog.json/records/108/iv_push/0/population | Historical; current review incomplete |
H51-B62D2138B852F6C66DA04336 | catalog.json/records/108/iv_push/0/dose_scope | Historical; current review incomplete |
H51-873AC67B3CE596D1EC0E61E2 | catalog.json/records/108/iv_push/0/concentration | Historical; current review incomplete |
H51-ABBC086E4BD63E41807A6CC2 | catalog.json/records/108/iv_push/0/rate | Historical; current review incomplete |
H51-55A2057EFA3AA3A7F1FC1882 | catalog.json/records/108/iv_push/0/status | Historical; current review incomplete |
H51-1515C3E886D6E75411DD271D | catalog.json/records/108/iv_push/0/notes | Historical; current review incomplete |
H51-EC851316D0F9CE146640B2FE | catalog.json/records/108/warnings/0 | Historical; current review incomplete |
H51-C2A83520987D2FA9C00DDB1E | catalog.json/records/108/monitoring/0 | Historical; current review incomplete |
H51-5B29D1B429243985A3A3E2B9 | catalog.json/records/108/monitoring/1 | Historical; current review incomplete |
H51-4BF36B8545661C1C150EA7F8 | catalog.json/records/108/populations/0 | Historical; current review incomplete |
H51-DD35A8A44B1DDFE22C6844C5 | catalog.json/records/108/populations/1 | Historical; current review incomplete |
H51-4971129418C3D541D6005582 | catalog.json/records/108/evidence_tier | Historical; current review incomplete |
H51-97495A9669B011929A344B7F | catalog.json/records/108/high_alert | Historical; current review incomplete |
H51-5993F1C581E0F9A2ADDB9EC3 | catalog.json/records/108/hazardous | Historical; current review incomplete |
H51-A42614378976E3E55312DD53 | catalog.json/records/108/status | Historical; current review incomplete |
H51-F2DBC72D459AB6BB2F8B030F | catalog.json/records/108/reviewed | Historical; current review incomplete |
H51-2E68DB2D3CA597C914A1492E | catalog.json/records/108/version_added | Historical; current review incomplete |
H51-B20F735E87ACF331C3C8B71F | catalog.json/records/108/sources/0 | Historical; current review incomplete |
H51-04DF916D7AC4CF656B550BEB | catalog.json/records/108/sources/0/label | Historical; current review incomplete |
H51-1BDA6854570C3BE7EB86ED46 | catalog.json/records/108/sources/0/url | Historical; current review incomplete |
H51-6189FAB664EAD22BE78E2D6C | catalog.json/records/108/sources/0/kind | Historical; current review incomplete |
H51-5E50C93BD3AD4B5DECC10CD3 | catalog.json/records/108/sources/1 | Historical; current review incomplete |
H51-03ACFFB2B81FD0D7D80B7091 | catalog.json/records/108/sources/1/label | Historical; current review incomplete |
H51-C67E839090C0FA4615A02EA5 | catalog.json/records/108/sources/1/url | Historical; current review incomplete |
H51-A150084A672149CDCC4B1222 | catalog.json/records/108/sources/1/kind | Historical; current review incomplete |
H51-4DE32EE72C524F2971BBE5BC | catalog.json/records/108/legacy_title | Historical; current review incomplete |
H51-8D1FC1E39D80F63EB82F431E | catalog.json/records/108/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-19F0C40C0FA7BD6A7D46D8FC | catalog.json/records/108/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-B57389CC94D9F813A138A12F | catalog.json/records/108/clinical_release_verification/level | Historical; current review incomplete |
H51-65B7D1ED2D0357E08D939D1F | catalog.json/records/108/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-9C7D755F55333C5606721021 | catalog.json/records/108/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-B417F5234B29745D16BDD311 | catalog.json/records/108/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-0D0E7912D799C345A8F6CBD4 | catalog.json/records/108/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-29480DEC6B49B8DE9614F025 | catalog.json/records/108/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-F2FA073E21A31903D32342DD | catalog.json/records/108/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-779801E33B323D303C0831DE | catalog.json/records/108/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-CE1F5EE6A5C0AAC8934894DB | catalog.json/records/108/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-636B0065BA47115D3FBF06DB | catalog.json/records/108/clinical_release_verification/note | Historical; current review incomplete |
H51-E82CA68B7A7DB525D4E8E385 | catalog.json/records/108/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-A5A8B5F596BD814A6677AF4E | dosing.json/records/108/id | Historical; current review incomplete |
H51-59C1B5B1CC66C9E8F862F265 | dosing.json/records/108/generic_name | Historical; current review incomplete |
H51-5A1A7B17FF9B2C7A7182472D | dosing.json/records/108/coverage_status | Historical; current review incomplete |
H51-F18AB8CC812FB273B1B9A610 | dosing.json/records/108/package_insert/query_name | Historical; current review incomplete |
H51-86F32E07D9AA74B303FEE98B | dosing.json/records/108/package_insert/preferred_setid | Historical; current review incomplete |
H51-7D70F1DB3049A938D1678F90 | dosing.json/records/108/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-52BEC780B69E756D8DBD7247 | dosing.json/records/108/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-97F0F1B0AEC5680BAC411176 | dosing.json/records/108/package_insert/source_priority | Historical; current review incomplete |
H51-FA08C8E867A021262619C0D5 | dosing.json/records/108/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-3C1D93FE7C328AE4DDCAACD2 | dosing.json/records/108/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-E579242C96C3A594A4484CDA | dosing.json/records/108/package_insert/local_summary_status | Historical; current review incomplete |
H51-CB91C2DB32BEAB2B4483B148 | dosing.json/records/108/renal/classification | Historical; current review incomplete |
H51-18F6FB4EE1FB74B7A20D3DFB | dosing.json/records/108/renal/summary | Historical; current review incomplete |
H51-9ECC91D1282D90789F3C1F29 | dosing.json/records/108/renal/method_note | Historical; current review incomplete |
H51-E44A24055E48E5F646915402 | dosing.json/records/108/existing_route_snapshots/0 | Historical; current review incomplete |
H51-22BBCB3654AC8A8B57B33417 | dosing.json/records/108/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-7FB471E445E21D3B4FD344E9 | dosing.json/records/108/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-4CC46D9A169F1A2EA5CD8750 | dosing.json/records/108/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-9A1B6B314452D878A8E4F320 | dosing.json/records/108/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-BACD3BFD6344E02D8C9C8B09 | dosing.json/records/108/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-B321E2C18E9894FA78CBE592 | dosing.json/records/108/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-FF1EB77A6CA91F3E75516650 | dosing.json/records/108/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-C0DE95C51320DAB3177E9D06 | dosing.json/records/108/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-F1BD0A10A0CF790E9ACC068F | dosing.json/records/108/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-9463D2FC1DBFD36254C4FFED | dosing.json/records/108/clinical_review/locally_normalized | Historical; current review incomplete |
H51-DBCD43F2EF07BD135306E363 | dosing.json/records/108/clinical_review/reviewed | Historical; current review incomplete |
H51-E7BC296FA4B017DF765A2B53 | dosing.json/records/108/clinical_review/status | Historical; current review incomplete |
H51-487C4E39774F3E5917685037 | dosing.json/records/108/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-5DB12BBCF4C885022C37EFEB | dosing.json/records/108/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-A7528717B895FE36D26E64A5 | dosing.json/records/108/clinical_release_verification/level | Historical; current review incomplete |
H51-8D3E68F86D9865427282C8EF | dosing.json/records/108/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-FF98B2B2A4C46FB38802481A | dosing.json/records/108/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-5C750D622439A1BF5EB9152D | dosing.json/records/108/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-0695F81B75410DB9DF6DEF04 | dosing.json/records/108/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-0273983B8EC80D1CEA0535CC | dosing.json/records/108/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-DADEF4F17A6456EB0C806033 | dosing.json/records/108/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-1D2D0C2F06AC527314642A9D | dosing.json/records/108/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-256C6F94A77CE0FCE94F9971 | dosing.json/records/108/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-665CC2F64ECCC4515E896C46 | dosing.json/records/108/clinical_release_verification/note | Historical; current review incomplete |
H51-763524DE79CAB7219C6BEA10 | dosing.json/records/108/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-A59D80C3A1B063A2EC9EEECA | first-look-v5.1.json/records/108/id | Historical; current review incomplete |
H51-DDECFC27E31115782F6CFF70 | first-look-v5.1.json/records/108/generic_name | Historical; current review incomplete |
H51-D6A1CD294D0EC4B229578E7C | first-look-v5.1.json/records/108/class | Historical; current review incomplete |
H51-9E895B31D68D97806ABD0083 | first-look-v5.1.json/records/108/subclass | Historical; current review incomplete |
H51-4BF0F6586649C415229B8253 | first-look-v5.1.json/records/108/primary_uses/0 | Historical; current review incomplete |
H51-AB34B9B59FE23AF31F4E2BF2 | first-look-v5.1.json/records/108/mechanism | Historical; current review incomplete |
H51-E4C937F68D91D789C1710116 | first-look-v5.1.json/records/108/mechanism_level | Historical; current review incomplete |
H51-AE4A7467B35980DEE1FD01A4 | first-look-v5.1.json/records/108/basic_dosing_orientation | Historical; current review incomplete |
H51-3E73CC4582F4B1A01D078C84 | first-look-v5.1.json/records/108/administration_orientation | Historical; current review incomplete |
H51-B93439B713B0C7B05767FE65 | first-look-v5.1.json/records/108/renal_and_population_orientation | Historical; current review incomplete |
H51-4991D317F8B2330B73F660F7 | first-look-v5.1.json/records/108/key_safety_orientation/0 | Historical; current review incomplete |
H51-9C14DCA6BA8B3616ED297AE4 | first-look-v5.1.json/records/108/coverage_path | Historical; current review incomplete |
H51-34A748B4648A9AF9F843E885 | first-look-v5.1.json/records/108/coverage_path_label | Historical; current review incomplete |
H51-F5B51E1C04998957F7C2C4FC | first-look-v5.1.json/records/108/official_label_url | Historical; current review incomplete |
H51-AC1FC25E095FDF30CFBCB0A2 | first-look-v5.1.json/records/108/legacy_title | Historical; current review incomplete |
H51-D740C5A8C1398B729311B876 | first-look-v5.1.json/records/108/review_note | Historical; current review incomplete |
H51-18CC0151E816377FA36F9E95 | first-look-v5.1.json/records/108/search_text | Historical; current review incomplete |
H51-45904281CCBC9BC48048F2CA | first-look-v5.1.json/records/108/official_search_url | Historical; current review incomplete |
H51-5D08C0094553F4D78D2C61BF | first-look-v5.1.json/records/108/official_access_mode | Historical; current review incomplete |
H51-4C4641A1FD7C72E924FD3123 | first-look-v5.1.json/records/108/official_access_url | Historical; current review incomplete |
H51-C942810809610F36A7510A56 | first-look-v5.1.json/records/108/official_search_query | Historical; current review incomplete |
H51-6E722E705C10051089BFF78F | first-look-v5.1.json/records/108/official_access_reason | Historical; current review incomplete |
H51-F0468BDDD09549323F517F5F | preparation-assessments-v3.8.json/108/id | Historical; current review incomplete |
H51-6F62DAD0E538CCB804264A54 | preparation-assessments-v3.8.json/108/name | Historical; current review incomplete |
H51-4258E0AA1B2E84077A7AE537 | preparation-assessments-v3.8.json/108/brands | Historical; current review incomplete |
H51-FFAACD71C3BBD09972F9CCE1 | preparation-assessments-v3.8.json/108/therapeutic_class | Historical; current review incomplete |
H51-FF5F6008EAD21846B4F3C2F7 | preparation-assessments-v3.8.json/108/review_version | Historical; current review incomplete |
H51-ABB512320CE259F9506F0AA3 | preparation-assessments-v3.8.json/108/review_date | Historical; current review incomplete |
H51-5EF4E9AFEE442A2FDEA80A04 | preparation-assessments-v3.8.json/108/release_status | Historical; current review incomplete |
H51-C82DABAAB52831B6F67A7057 | preparation-assessments-v3.8.json/108/market_status/status | Historical; current review incomplete |
H51-3353BA8D1A3A387C7F840831 | preparation-assessments-v3.8.json/108/market_status/basis | Historical; current review incomplete |
H51-9B1C653030FA4F6724E7247B | preparation-assessments-v3.8.json/108/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-A0C12D3858124A69E2F8486B | preparation-assessments-v3.8.json/108/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-688057A34A0CB675826B929E | preparation-assessments-v3.8.json/108/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-8690E1BDAA41D76598E1FE07 | preparation-assessments-v3.8.json/108/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-A2808C26F84F0CFE8568DBA1 | preparation-assessments-v3.8.json/108/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-E67745C374B9AD44A5BD86F4 | preparation-assessments-v3.8.json/108/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-F4E539B93F3EEAA1F9DF2B09 | preparation-assessments-v3.8.json/108/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-BB1C5A567E68E0264CF32BF9 | preparation-assessments-v3.8.json/108/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-8435466DCD5F7DB23AEA163C | preparation-assessments-v3.8.json/108/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-3B5808E5C18A55E84D9E5510 | preparation-assessments-v3.8.json/108/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-EFDE31247979F63186AE6694 | preparation-assessments-v3.8.json/108/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-F78594F2F46FB22B9FEB6D75 | preparation-assessments-v3.8.json/108/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-F298BF1E1CF38C1B69ECC6FE | preparation-assessments-v3.8.json/108/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-D7928D6AB939D2E784B983B4 | preparation-assessments-v3.8.json/108/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-A60DE9A4AF728D0ABD8E1840 | preparation-assessments-v3.8.json/108/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-49415E3B1F53C9BFE3C0C0AA | preparation-assessments-v3.8.json/108/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-419FAC9FD09ADC4239127F5B | preparation-assessments-v3.8.json/108/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-70E07A17C57CD81E1C148A06 | preparation-assessments-v3.8.json/108/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-C3DE0139040881F717A48B2E | preparation-assessments-v3.8.json/108/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-43CF71406BD473E8440B4992 | preparation-assessments-v3.8.json/108/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-D884E8C33811494053E8F079 | preparation-assessments-v3.8.json/108/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-4ED29EA006C12B2BB69DB61A | preparation-assessments-v3.8.json/108/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-7E5EFE725127E9E24EA5E5C9 | preparation-assessments-v3.8.json/108/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-A7375FB1B2BAAA53BD597E6D | preparation-assessments-v3.8.json/108/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-2E43D2639416275ED2E575DB | preparation-assessments-v3.8.json/108/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-EC156498834F7D8FFB5899B6 | preparation-assessments-v3.8.json/108/population_applicability/adult/applicability | Historical; current review incomplete |
H51-83E33D6D821FC7AE4C981917 | preparation-assessments-v3.8.json/108/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-0A20A77C978303363ABA8430 | preparation-assessments-v3.8.json/108/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-41EBB2F1AE5BFF897BA612E2 | preparation-assessments-v3.8.json/108/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-8641A0FA964068ED896A1835 | preparation-assessments-v3.8.json/108/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-48238186974C9C7B082CDCC8 | preparation-assessments-v3.8.json/108/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-49A331A1DF350A63BB237D3A | preparation-assessments-v3.8.json/108/route_presence/structured_dilution | Historical; current review incomplete |
H51-624E5932FAFAE01B83E8359B | preparation-assessments-v3.8.json/108/route_presence/iv_push | Historical; current review incomplete |
H51-A9718D6869DB9977EC9AC7DD | preparation-assessments-v3.8.json/108/route_presence/continuous_infusion | Historical; current review incomplete |
H51-BEA49774EBCEFFAB53280FC1 | preparation-assessments-v3.8.json/108/route_presence/pediatric_source | Historical; current review incomplete |
H51-672EA922E2E0A7D73ACD8A04 | preparation-assessments-v3.8.json/108/route_presence/neonatal_source | Historical; current review incomplete |
H51-768095914F38CD91EC1E803F | preparation-assessments-v3.8.json/108/legacy_reference/status | Historical; current review incomplete |
H51-B37B5AAF03F14BEBFD9B9F34 | preparation-assessments-v3.8.json/108/label_resolution/status | Historical; current review incomplete |
H51-291DA3888478161960BEDD6A | preparation-assessments-v3.8.json/108/source_files/0 | Historical; current review incomplete |
H51-56E9C1C4CC3BDCB9AA95E771 | preparation-assessments-v3.8.json/108/source_files/1 | Historical; current review incomplete |
H51-AA3A9439969C7FD5DE97AC40 | preparation-assessments-v3.8.json/108/source_files/2 | Historical; current review incomplete |
H51-E9715951279E61CA6020C32B | preparation-assessments-v3.8.json/108/clinical_release_note | Historical; current review incomplete |